Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Part of paid clinical trials in Buffalo, New York.
- Sponsor
- Insulet Corporation
- Study ID
- NCT06144554
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Omnipod 5 — DEVICEThe Omnipod 5 System consists of a tubeless insulin Pod and the Omnipod® 5 App, installed on a designated Controller or compatible Android smartphone. The Omnipod 5 System works with the Dexcom G6® Continuous Glucose Monitoring System to continuously adapt and automatically deliver insulin according to personal needs. Every two weeks while on the Omnipod 5 system, participants will receive a push notification to complete assessments including any severe hypoglycemia or diabetic ketoacidosis events experienced since the prior assessment.
Study Details
This is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
Key Dates
- Start date
- Sep 25, 2023
- Status verified
- May 2025
- Primary completion
- Jun 30, 2027
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 2,200 participants (estimated)
Arms
- Arm: Omnipod UserAll new users for the Omnipod 5 System will be required to register with Insulet's Podder Central. Users already in Podder Central will be required to log into their account before logging into the Omnipod 5 Controller if transitioning to the Omnipod 5 System. As part of the onboarding process, users will be invited to participate in this registry.
Primary Outcome Measure
Incidence rate of severe hypoglycemia [ Time Frame: From baseline to study completion, up to 12 months. ]
Central Contacts
- Trang Ly, MBBS, PhD978-600-7000
- Julie Perkins978-600-7000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Circuit Clinical | Buffalo | New York | 14203 | Ashok Subramanian, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Buffalo, NY
By condition
By specialty
By research site
Related Studies
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama
- Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 DiabetesRecruiting · Albert Einstein College of Medicine · New York, New York
- Cholesterol Lowering and Residual Risk in Diabetes, Type 1PHASE4 · Recruiting · NYU Langone Health · New York, New York
- Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and DepressionRecruiting · Albert Einstein College of Medicine · Boston, Massachusetts